Evidence map›Paper›PMID 17975670›Full record

ArticleThe Journal of clinical investigation2007

The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.

Chao-Ling Yang, Xiaoman Zhu, David H Ellison

Open access · hybridAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Article
  3. The evolving concepts of KS-WNK1 effect on NCC activity.American journal of physiology. Renal physiology · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Soluble (Pro)Renin Receptor as a Negative Regulator of NCC (NaHypertension (Dallas, Tex. : 1979) · 2021
    Article
  10. WNK4 kinase: from structure to physiology.American journal of physiology. Renal physiology · 2021
    Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. GABANature communications · 2017
    Article
  17. CD8Nature communications · 2017
    Article
  18. Article
  19. Potassium and Its Discontents: New Insight, New Treatments.Journal of the American Society of Nephrology : JASN · 2016
    Review
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Chao-Ling YangDivision of Nephrology & Hypertension, Department of Medicine, Oregon Health & Science University, Portland, Oregon 97239, USA. yangch@ohsu.edu
Xiaoman Zhu
David H Ellison
Oregon Health & Science University · USHypertension Institute · US

Funding

WNK Kinase Regulation of Thiazide-sensitive NaCl TransportR01DK051496 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI David Hoadley Ellison, CHAO-LING YANG · 1998 to 2026
$8.4M
NIDDK NIH HHS DK51496NIDDK NIH HHS R01 DK051496
6 · The paper itself

Abstract

The pathogenesis of essential hypertension remains unknown, but thiazide diuretics are frequently recommended as first-line treatment. Recently, familial hyperkalemic hypertension (FHHt) was shown to result from activation of the thiazide-sensitive Na-Cl cotransporter (NCC) by mutations in WNK4, although the mechanism for this effect remains unknown. WNK kinases are unique members of the human kinome, intimately involved in maintaining electrolyte balance across cell membranes and epithelia. Previous work showed that WNK1, WNK4, and a kidney-specific isoform of WNK1 interact to regulate NCC activity, suggesting that WNK kinases form a signaling complex. Here, we report that WNK3, another member of the WNK kinase family expressed by distal tubule cells, interacts with WNK4 and WNK1 to regulate NCC in both human kidney cells and Xenopus oocytes, further supporting the WNK signaling complex hypothesis. We demonstrate that physiological regulation of NCC in oocytes results from antagonism between WNK3 and WNK4 and that FHHt-causing WNK4 mutations exert a dominant-negative effect on wild-type (WT) WNK4 to mimic a state of WNK3 excess. The results provide a mechanistic explanation for the divergent effects of WT and FHHt-mutant WNK4 on NCC activity, and for the dominant nature of FHHt in humans and genetically modified mice.

Indexed as

Amino Acid SequenceAnimalsCell LineClaudinsHumansIntracellular Signaling Peptides and ProteinsKidneyMembrane ProteinsMiceMinor Histocompatibility AntigensMolecular Sequence DataOocytesPhosphorylationProtein Serine-Threonine KinasesRatsReceptors, Drugclaudin protein, XenopusClaudinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsMinor Histocompatibility AntigensProtein Serine-Threonine KinasesReceptors, DrugRecombinant Fusion ProteinsSodium Chloride Symportersthiazide receptorThiazidesWNK1 protein, humanWNK3 protein, humanWNK4 protein, humanWNK Lysine-Deficient Protein Kinase 1Xenopus Proteins

Identifiers

PMID17975670
PMCPMC2045602
OpenAlexW2098922682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.